Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.4900 (-1.88%) ($5.3700 - $5.7300) on Wed. Sep. 2, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.55% (three month average) | RSI | 43 | Latest Price | $5.4900(-1.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.5% a day on average for past five trading days. | Weekly Trend | CAPR declines -6.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) TIP(96%) IGOV(30%) VIXM(18%) VCIT(61%) TLT(40%) | Factors Impacting CAPR price | CAPR will decline at least -4.275% in a week (0% probabilities). URA(-41%) XLB(-35%) PAVE(-30%) OIH(-27%) XOP(-26%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.275% (StdDev 8.55%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-17.64(-421.31%) | Resistance Level | $6.03 | 5 Day Moving Average | $5.49(0%) | 10 Day Moving Average | $5.62(-2.31%) | 20 Day Moving Average | $6.03(-8.96%) | To recent high | -44% | To recent low | 9.6% | Market Cap | $108m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |